Morys-Wortmann C - Search Results

1

GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro.

Gallwitz B, Ropeter T, Morys-Wortmann C, Mentlein R, Siegel EG, Schmidt WE. Gallwitz B, et al. Among authors: morys wortmann c. Regul Pept. 2000 Jan 29;86(1-3):103-11. doi: 10.1016/s0167-0115(99)00095-6. Regul Pept. 2000. PMID: 10672909

2

GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1.

Gallwitz B, Witt M, Morys-Wortmann C, Fölsch UR, Schmidt WE. Gallwitz B, et al. Regul Pept. 1996 May 7;63(1):17-22. doi: 10.1016/0167-0115(96)00019-5. Regul Pept. 1996. PMID: 8795084

3

Biological activity of GLP-1-analogues with N-terminal modifications.

Siegel EG, Gallwitz B, Scharf G, Mentlein R, Morys-Wortmann C, Fölsch UR, Schrezenmeir J, Drescher K, Schmidt WE. Siegel EG, et al. Among authors: morys wortmann c. Regul Pept. 1999 Feb 5;79(2-3):93-102. doi: 10.1016/s0167-0115(98)00155-4. Regul Pept. 1999. PMID: 10100921

4

Comparison of the effect of native glucagon-like peptide 1 and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic islets.

Siegel EG, Scharf G, Gallwitz B, Mentlein R, Morys-Wortmann C, Fölsch UR, Schmidt WE. Siegel EG, et al. Among authors: morys wortmann c. Eur J Clin Invest. 1999 Jul;29(7):610-4. doi: 10.1046/j.1365-2362.1999.00440.x. Eur J Clin Invest. 1999. PMID: 10411667

5

Structure/activity characterization of glucagon-like peptide-1.

Gallwitz B, Witt M, Paetzold G, Morys-Wortmann C, Zimmermann B, Eckart K, Fölsch UR, Schmidt WE. Gallwitz B, et al. Eur J Biochem. 1994 Nov 1;225(3):1151-6. doi: 10.1111/j.1432-1033.1994.1151b.x. Eur J Biochem. 1994. PMID: 7957206 Free article.

6

Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity.

Schäfer H, Zheng J, Morys-Wortmann C, Fölsch UR, Schmidt WE. Schäfer H, et al. Among authors: morys wortmann c. Regul Pept. 1999 Feb 5;79(2-3):83-92. doi: 10.1016/s0167-0115(98)00147-5. Regul Pept. 1999. PMID: 10100920

7

Specific monoclonal antibodies neutralize the action of PACAP 1-27 or PACAP 1-38 on intestinal muscle strips in vitro.

Schwarzhoff R, Schwörer H, Fornefeld H, Morys-Wortmann C, Katsoulis S, Creutzfeldt W, Fölsch UR, Schmidt WE. Schwarzhoff R, et al. Regul Pept. 1995 Jan 5;55(1):57-66. doi: 10.1016/0167-0115(94)00092-c. Regul Pept. 1995. PMID: 7724828

8

Human galanin modulates human colonic motility in vitro. Characterization of structural requirements.

Katsoulis S, Clemens A, Morys-Wortmann C, Schwörer H, Schaube H, Klomp HJ, Fölsch UR, Schmidt WE. Katsoulis S, et al. Scand J Gastroenterol. 1996 May;31(5):446-51. doi: 10.3109/00365529609006763. Scand J Gastroenterol. 1996. PMID: 8734340

9

Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptors.

Clemens A, Katsoulis S, Nustede R, Seebeck J, Seyfarth K, Morys-Wortmann C, Feurle GE, Fölsch UR, Schmidt WE. Clemens A, et al. Among authors: morys wortmann c. Am J Physiol. 1997 Jan;272(1 Pt 1):G190-6. doi: 10.1152/ajpgi.1997.272.1.G190. Am J Physiol. 1997. PMID: 9038893

10

Identification and biochemical characterization of the human brain galanin receptor.

Walli R, Schäfer H, Morys-Wortmann C, Paetzold G, Nustede R, Schmidt WE. Walli R, et al. J Mol Endocrinol. 1994 Dec;13(3):347-56. doi: 10.1677/jme.0.0130347. J Mol Endocrinol. 1994. PMID: 7534460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page